Post-traumatic stress disorder and adverse pregnancy and birth outcomes: a population-based study Authors: Yu-Chieh Huang, Senyeong Kao, Hui-Wen Yang, Pei-Xun Zhong, Sheng-Yin To, Li-Ting Kao Published: 2026 ABSTRACT ABSTRACTBackground: Post-traumatic stress disorder (PTSD) is associated with functional impairment and primarily affects women, with potential impacts on reproductive health. However, evidence regarding pregnancy and neonatal outcomes among women with PTSD prior to delivery remains limited.Objective: To examine whether PTSD is associated with adverse pregnancy and neonatal outcomes in a nationwide population-based cohort of women in Taiwan.Method: This population-based matched cohort study used Taiwan’s Birth Reporting and National Health Insurance Research Database. Pregnant women with PTSD within 1 year before delivery were identified and matched 1:1 with comparison subjects using propensity scores. Primary outcomes included adverse pregnancy outcomes (cesarean delivery, stillbirth) and neonatal outcomes (low birth weight, preterm birth, small for gestational age, abnormal 5-minute Apgar score, and congenital defects). Logistic regression was used to calculate adjusted odds ratios (aORs) and 95% confidence intervals (CIs).Results: The matched cohorts included 4,353 women with PTSD and 4,353 without PTSD. Relevant findings show that PTSD was associated with increased risks of cesarean delivery (aOR 1.18; 95% CI 1.08–1.28), low birth weight (aOR 1.19; 95% CI 1.04–1.37), and preterm birth (aOR 1.21; 95% CI 1.06–1.38). These associations were more obvious among women aged ≤ 35 years and those with gestational diabetes or anemia. Nevertheless, no significant associations were observed for stillbirth, small for gestational age, abnormal Apgar scores, or congenital anomalies.Conclusions: Pre-delivery PTSD slightly increased risks of cesarean delivery, low birth weight, and preterm birth. However, the lack of association with severe neonatal outcomes, such as congenital anomalies and stillbirth, provides essential reassurance. These findings underscore the importance of integrating mental health monitoring into routine prenatal care to optimise maternal and infant well-being without causing undue alarm. Introduction Post-traumatic stress disorder (PTSD) is a psychiatric condition defined by four core symptom clusters: re-experiencing, avoidance, negative alterations in cognition and mood, and alterations in arousal and reactivity (American Psychiatric Association, 2022). The prevalence of PTSD varies across populations. The National Comorbidity Survey Replication in the United States reported a lifetime prevalence of 6.8% (Elhai et al., 2008), cross-national surveys have estimated rates of approximately 3.9% (Koenen et al., 2017), and recent systematic reviews report rates up–23.95% in high-risk populations (Schincariol et al., 2024). Individuals with PTSD experience reduced productivity and increased risks of chronic physical diseases and neurodegeneration (Jellestad et al., 2021; Roberts et al., 2022), contributing to substantial life burden and diminished role functioning. The burden of PTSD disproportionately affects women. Approximately 69% of women experience at least one lifetime traumatic event (Resnick et al., 1993), but female trauma exposure may have been historically underestimated (Mills et al., 2011). Although men often report higher rates of trauma exposure, women are consistently shown to be twice as likely as men to develop PTSD following such events (Haering, Meyer, et al., 2024; Olff, 2017). Sensitivity to hormonal fluctuations may underlie women's vulnerability to stress-related disorders, and biological mechanisms may contribute to sex differences in fear and anxiety (Oliver et al., 2025; Stevens et al., 2025). The marked gender disparity in PTSD holds implications for advancing gender-sensitive and sex-sensitive research in the field of reproductive health (Haering, Schulze, et al., 2024; Jacobs, 2023). During the perinatal period, the prevalence of PTSD among pregnant women is approximately 8% to 11% (Padin et al., 2022; Seng et al., 2009), while community-based studies report postpartum PTSD prevalence rates ranging from 3.1% to 24.5% (Alemu et al., 2024; Grekin & O'Hara, 2014; Liu et al., 2021; Schwab et al., 2012). Although PTSD symptoms can stabilise or improve during pregnancy owing to rising progesterone levels (Muzik et al., 2016; Rocha et al., 2025), many pregnant women do not disclose their PTSD status to their obstetricians (Padin et al., 2022; Powers et al., 2020). While social support serves as a vital protective factor promoting resilience among high-risk women, pregnancy-specific stressors, labor-related anxiety, and total lifetime PTSD load may exacerbate symptoms (Muzik et al., 2016), highlighting the need for culturally responsive trauma screening in obstetric settings (Powers et al., 2020). A growing body of evidence has underscored the consequences of perinatal-onset PTSD, the risk factors for childbirth-related PTSD, and the impact of negative childbirth experiences (Bosquet Enlow et al., 2011; Handelzalts et al., 2025; Kranenburg et al., 2023; Murawska et al., 2026; Van Sieleghem et al., 2022; Webb et al., 2025; Yildiz et al., 2017). Maternal PTSD can impair the mother–child relationship, infant emotional regulation and developmental trajectories, and family bonding (Bowers & Yehuda, 2016; Calpbinici, 2024). To date, most perinatal research has documented increased risks of preterm birth and low birth weight associated with maternal PTSD, with risks further heightened when the trauma involves abuse (Sanjuan et al., 2021; Seng et al., 2011; Xiong et al., 2008; Yonkers et al., 2014; Zitoun et al., 2025). Stressors including anxiety, pain, fatigue, low subjective well-being, and inadequate family support have been identified as deleterious factors associated with preterm birth in the context of maternal PTSD (Becker et al., 2023). However, advanced maternal age (greater than 35 years) and maternal medical and psychiatric comorbidities, such as gestational diabetes, gestational hypertension, anxiety, and depression, are also independent risk factors for preterm birth and low birth weight in offspring (Diabelková et al., 2024; Greco et al., 2024; Nasreen et al., 2019; Perejón et al., 2024; Voit et al., 2022). From a clinical perspective, it is critical to determine whether these physiological and psychological vulnerabilities compound the adverse effects of PTSD, or whether the risk remains uniform across different clinical strata. Few studies have examined the effects of PTSD within these high-risk clinical subgroups. We a priori planned stratified assessments to evaluate the robustness of the associations across these strata, rather than to formally test for effect modification. As most studies remain limited to specific urban areas, there is a notable scarcity of nationwide data from large-scale, non-Western populations, which restricts the generalizability of existing findings across diverse cultural and healthcare settings. Limited research has examined adverse pregnancy outcomes and offspring health among women with PTSD diagnosed prior to delivery. To address this gap, the present study used a population-based dataset from Taiwan to investigate the risk of adverse pregnancy and neonatal outcomes among women with pre-existing PTSD diagnosed before delivery. Methods Data sources Data for this study were obtained from two linked population-based databases in Taiwan: the Birth Reporting Database and the National Health Insurance Research Database (NHIRD). The Birth Reporting Database, maintained by the Ministry of Health and Welfare, contains comprehensive nationwide records of all births, including maternal delivery information and neonatal outcomes such as birth weight, gestational age at delivery, Apgar scores, and congenital anomalies. The NHIRD, which covers over 99% of Taiwan’s population, provides longitudinal claims data encompassing patients’ diagnoses, medical procedures, prescribed medications, and demographic characteristics collected through the National Health Insurance programme (Hsieh et al., 2019). The two databases were linked via anonymized identifiers to safeguard privacy and ensure data integrity. Study design and PTSD definition This population-based cohort study examined the associations of maternal PTSD with adverse pregnancy outcomes and offspring birth outcomes. The study period encompassed all births from 1 January 2004 to 31 December 2021. To ensure that each woman contributed only one pregnancy to the analysis, the linked cohort comprised only the first mother–infant pair per woman during this interval (n = 3,346,688). To ensure data quality and validity, we then excluded women aged <15 or >55 years (n = 21,363), births with unknown offspring sex (n = 1,113), and records with missing maternal baseline characteristics (n = 103). After applying these exclusion criteria, the final analytic sample comprised 3,324,109 mother–infant pairs. Among them, women with PTSD were identified as the exposed group (n = 4,485), whereas those without PTSD constituted the unexposed comparison group (n = 3,319,624) (Figure 1). PTSD status was ascertained from the NHIRD based on the first recorded diagnosis using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 309.81 or the Tenth Revision (ICD-10) codes F43.10, F43.11, or F43.12 within one year prior to delivery. Women without a PTSD diagnosis during this period were categorised as the comparison group. Figure 1.Flowchart of sample selection.A flowchart diagram showing a 2004 to 2021 birth cohort and exclusions, ending with matched mothers with and without PTSD in a PSM cohort.The figure shows a flowchart diagram outlining sample selection for a population based birth cohort. At the top, a large box states that the cohort includes first mother infant pairs from 2004 to 2021 with a total of 3,346,688 pairs. A right pointing arrow leads to a dashed box labeled exclusion criteria, listing 21,363 records excluded for maternal age less than 15 or greater than 55 years, 1,113 records excluded for missing infant sex, and 103 records excluded for missing maternal baseline characteristics. A downward arrow from the initial cohort box, after applying exclusions, leads into a broad shaded band labeled full cohort. Within this band, 2 side by side rectangles show 2 groups: on the left, mothers with post traumatic stress disorder, count 4,485; on the right, mothers without post traumatic stress disorder, count 3,319,624. From each of these 2 boxes, a downward arrow continues into a second shaded band labeled propensity score matched cohort. Here, 2 final rectangles show matched groups: on the left, mothers with post traumatic stress disorder, count 4,353; on the right, mothers without post traumatic stress disorder, count 4,353. The arrows indicate the progression from the original cohort through exclusions to the full cohort and then to the matched cohort counts. Flowchart of sample selection. To minimise selection bias and balance baseline characteristics between mother with and without PTSD, we performed 1:1 propensity score matching. Propensity scores were estimated using logistic regression models that included maternal characteristics (age, geographic region, monthly insured salary, and comorbidities) and offspring sex. This procedure produced two matched cohorts of 4,353 women with PTSD and 4,353 women without PTSD for the primary analysis. Outcome variables The primary outcomes were adverse pregnancy outcomes and offspring birth outcomes, as identified from the Birth Reporting Database (detailed definitions are summarised in Supplementary Table 1). Adverse pregnancy outcomes included cesarean section and stillbirth. Cesarean section was defined as any delivery performed by surgical procedure, and stillbirth as fetal death occurring at or beyond 20 gestational weeks or with a birth weight of at least 500 g. Offspring birth outcomes included low birth weight, preterm birth, small for gestational age (SGA), abnormal 5-minute Apgar score, and congenital anomalies. Low birth weight was defined as birth weight <2,500 g, and preterm birth as gestational age <37 weeks. SGA was defined as birth weight below the 10th percentile for gestational age and sex, according to population-specific Taiwanese neonatal growth standards, with thresholds defined for gestational weeks 21–44 and stratified by sex. An abnormal 5-minute Apgar score was defined as <7. Congenital anomalies were further categorised by organ system, including nervous system anomalies (e.g. anencephaly, spina bifida), eye and facial anomalies (e.g. anophthalmia, cleft palate), cardiovascular anomalies (e.g. ventricular septal defect, tetralogy of Fallot), gastrointestinal anomalies (e.g. esophageal atresia, omphalocele), genitourinary anomalies (e.g. renal agenesis, hypospadias), musculoskeletal anomalies (e.g. limb reduction defects, clubfoot), respiratory anomalies (e.g. choanal atresia, lung hypoplasia), and chromosomal abnormalities (e.g. trisomy 21, Turner syndrome), among others. Confounders Several potential confounders were considered when examining the association between maternal PTSD and both adverse pregnancy outcomes and offspring birth outcomes. These variables included maternal demographics (maternal age, geographic region, and monthly insured salary), offspring sex, maternal pregnancy-related conditions (gestational diabetes mellitus and gestational hypertension), and pre-existing maternal comorbidities, including anemia, hyperlipidemia, coronary heart disease, depression, anxiety, alcohol use, tobacco use, and obesity. Pre-existing maternal comorbidities were identified within one year prior to delivery. A comprehensive list of all variables and their corresponding data sources is provided in Supplementary Table 1. Statistical analysis Baseline characteristics were summarised, with age presented as means ± standard deviations and other variables expressed as counts and percentages. Balance between the groups was assessed using standardised differences, with values <0.1 indicating adequate balance. Associations between maternal PTSD and adverse pregnancy outcomes as well as offspring birth outcomes were examined using multivariable logistic regression models in the matched cohort. Results were reported as odds ratios (ORs), adjusted odds ratios (aORs), and 95% confidence intervals (CIs). Models were adjusted for maternal characteristics (age, geographic region, monthly insured salary, and comorbidities) and offspring sex. All statistical tests were two-sided, with statistical significance defined as p < .05. Data management and analyses were performed using SAS version 9.4. Subgroup analysis Subgroup analyses were performed to evaluate the consistency of the associations between maternal PTSD and both adverse pregnancy outcomes and offspring birth outcomes across clinically relevant maternal characteristics. Subgroups were stratified according to maternal age group (≤35 and >35 years) and the presence of selected maternal comorbidities, including gestational diabetes mellitus, gestational hypertension, anxiety, depression, and anemia, which were selected based on prior literature and their associations with adverse pregnancy and birth outcomes (Beckert et al., 2019; Ding et al., 2014; Frick, 2021; Ye et al., 2022). Within each subgroup, logistic regression models were fitted to estimate crude and adjusted ORs with 95% CIs, using the same adjustment set as in the main analysis. Ethics approval This study was reviewed by the Tri-Service General Hospital Institutional Review Board (TSGHIRB C202405054). Results The baseline demographic, comorbidity, and offspring characteristics of pregnant women with and without PTSD after propensity score matching are presented in Table 1. The matched cohorts included 4,353 women with PTSD and 4,353 women without PTSD. The mean age was 30.37 ± 5.70 years in the PTSD group and 30.36 ± 5.71 years in the non-PTSD group. Geographic distribution and monthly insured salary were also well balanced between the two groups. With respect to comorbidities, there were no significant differences between women with and without PTSD in the prevalence of gestational diabetes mellitus, gestational hypertension, anemia, hyperlipidemia, coronary heart disease, or obesity. Likewise, mental health conditions, alcohol and tobacco use, and offspring sex were comparable between the two groups. Overall, all baseline demographic, comorbidities, and offspring characteristics demonstrated excellent balance, with all standardised differences below the threshold of 0.1, confirming adequate comparability between the matched cohorts. Table 1.Baseline demographics and comorbidities of pregnant women with and without PTSD.VariablesAfter propensity score matchingStandardised differenceaPregnant women with PTSD (n = 4353)Matched pregnant women without PTSD (n = 4353)Mother’s demographics Age (SD)30.37 (5.70)30.36 (5.71)0.0019 Geographic region 0.0112 North4309 (98.99)4304 (98.87) Central44 (1.01)49 (1.13) Monthly insured salary 0.0247 0–180001015 (23.32)1009 (23.18) 18001–350002327 (53.46)2335 (53.64) >350001011 (23.23)1009 (23.18) Mother’s comorbidities Gestational diabetes mellitus854 (19.62)860 (19.76)−0.0035 Gestational hypertension215 (4.94)218 (5.01)−0.0032 Anemia578 (13.28)582 (13.37)−0.0027 Hyperlipidemia151 (3.47)151 (3.47)<0.0001 Coronary heart disease33 (0.76)34 (0.78)−0.0026 Depression1104 (25.36)1105 (25.38)−0.0005 Anxiety1329 (30.53)1329 (30.53)<0.0001 Alcohol use29 (0.67)29 (0.67)<0.0001 Tobacco use84 (1.93)84 (1.93)<0.0001 Obesity29 (0.67)32 (0.74)−0.0083Offspring characteristics <0.0001 Female2076 (47.69)2076 (47.69) Male2277 (52.31)2277 (52.31) Notes: aVariables were considered to be balanced between groups if standardised difference <0.1. Table 1.Baseline demographics and comorbidities of pregnant women with and without PTSD.VariablesAfter propensity score matchingStandardised differenceaPregnant women with PTSD (n = 4353)Matched pregnant women without PTSD (n = 4353)Mother’s demographics Age (SD)30.37 (5.70)30.36 (5.71)0.0019 Geographic region 0.0112 North4309 (98.99)4304 (98.87) Central44 (1.01)49 (1.13) Monthly insured salary 0.0247 0–180001015 (23.32)1009 (23.18) 18001–350002327 (53.46)2335 (53.64) >350001011 (23.23)1009 (23.18) Mother’s comorbidities Gestational diabetes mellitus854 (19.62)860 (19.76)−0.0035 Gestational hypertension215 (4.94)218 (5.01)−0.0032 Anemia578 (13.28)582 (13.37)−0.0027 Hyperlipidemia151 (3.47)151 (3.47)<0.0001 Coronary heart disease33 (0.76)34 (0.78)−0.0026 Depression1104 (25.36)1105 (25.38)−0.0005 Anxiety1329 (30.53)1329 (30.53)<0.0001 Alcohol use29 (0.67)29 (0.67)<0.0001 Tobacco use84 (1.93)84 (1.93)<0.0001 Obesity29 (0.67)32 (0.74)−0.0083Offspring characteristics <0.0001 Female2076 (47.69)2076 (47.69) Male2277 (52.31)2277 (52.31) Notes: aVariables were considered to be balanced between groups if standardised difference <0.1. Baseline demographics and comorbidities of pregnant women with and without PTSD. Notes: aVariables were considered to be balanced between groups if standardised difference <0.1. The occurrence and risk of adverse pregnancy outcomes among women with PTSD compared to those without PTSD, after propensity score matching, are presented in Table 2. In the PTSD group, adverse pregnancy outcomes occurred in 41.76% for cesarean section, 1.03% for stillbirth, 12.20% for low birth weight, 13.35% for preterm birth, 5.81% for SGA, 1.63% for abnormal 5-minute Apgar score, and 0.60% for congenital defects. In the matched non-PTSD group, the corresponding adverse pregnancy outcomes were 38.18% for cesarean section, 1.06% for stillbirth, 10.59% for low birth weight, 11.46% for preterm birth, 5.56% for SGA, 1.31% for abnormal 5-minute Apgar score, and 0.83% for congenital defects. Several significant associations were identified. Women with PTSD had higher risks of cesarean section (OR: 1.161, 95% CI: 1.066–1.265, p < .01), low birth weight (OR: 1.173, 95% CI: 1.027–1.339, p < .05), and preterm birth (OR: 1.190, 95% CI: 1.047–1.352, p < .01). After adjusting for baseline characteristics and comorbidities, the increased risks remained significant for cesarean section (aOR: 1.175, 95% CI: 1.075–1.283, p < .01), low birth weight (aOR: 1.194, 95% CI: 1.042–1.369, p < .05), and preterm birth (aOR: 1.211, 95% CI: 1.062–1.382, p < .01), whereas no significant differences were noted for stillbirth, SGA, abnormal 5-minute Apgar score, or congenital defects. Table 2.Occurrence and risk of adverse pregnancy outcomes in women with PTSD.Adverse pregnancy outcomes (Mother with PTSD vs. Mother without PTSD)Pregnant women with PTSD (n = 4353)Matched pregnant women without PTSD (n = 4353)After propensity score matchingCrude ORAdjust ORaCesarean section1818 (41.76)1662 (38.18)1.161** (1.066–1.265)1.175** (1.075–1.283)Stillbirth45 (1.03)46 (1.06)1.022 (0.676–1.545)1.019 (0.674–1.542)Low birth weight531 (12.20)461(10.59)1.173* (1.027–1.339)1.194* (1.042–1.369)Preterm581 (13.35)499 (11.46)1.19** (1.047–1.352)1.211** (1.062–1.382)Small for gestational age253 (5.81)242 (5.56)1.048 (0.874–1.257)1.057 (0.875–1.276)5 min Apgar score (abnormal)71 (1.63)57 (1.31)1.250 (0.88–1.775)1.254 (0.881–1.783)Congenital defect26 (0.60)36 (0.83)0.721 (0.434–1.195)0.724 (0.436–1.202)Notes: aadjustment for baseline characteristics and comorbidities. *p < .05 **p < .01. Table 2.Occurrence and risk of adverse pregnancy outcomes in women with PTSD.Adverse pregnancy outcomes (Mother with PTSD vs. Mother without PTSD)Pregnant women with PTSD (n = 4353)Matched pregnant women without PTSD (n = 4353)After propensity score matchingCrude ORAdjust ORaCesarean section1818 (41.76)1662 (38.18)1.161** (1.066–1.265)1.175** (1.075–1.283)Stillbirth45 (1.03)46 (1.06)1.022 (0.676–1.545)1.019 (0.674–1.542)Low birth weight531 (12.20)461(10.59)1.173* (1.027–1.339)1.194* (1.042–1.369)Preterm581 (13.35)499 (11.46)1.19** (1.047–1.352)1.211** (1.062–1.382)Small for gestational age253 (5.81)242 (5.56)1.048 (0.874–1.257)1.057 (0.875–1.276)5 min Apgar score (abnormal)71 (1.63)57 (1.31)1.250 (0.88–1.775)1.254 (0.881–1.783)Congenital defect26 (0.60)36 (0.83)0.721 (0.434–1.195)0.724 (0.436–1.202)Notes: aadjustment for baseline characteristics and comorbidities. *p < .05 **p < .01. Occurrence and risk of adverse pregnancy outcomes in women with PTSD. Notes: aadjustment for baseline characteristics and comorbidities. *p < .05 **p < .01. The comparison of adverse pregnancy outcomes between women with and without PTSD, stratified by maternal age, is summarised in Table 3. Among women aged ≤35 years, PTSD was significantly associated with higher odds of cesarean section (aOR: 1.220, 95% CI: 1.105–1.348, p < .001), and preterm birth (aOR: 1.197, 95% CI: 1.029–1.392, p < .05) after adjustment. No significant associations were observed for stillbirth, SGA, abnormal 5-minute Apgar score, or congenital defects in this age group. Among women aged >35 years, aORs for all adverse pregnancy outcomes, including cesarean section, stillbirth, low birth weight, preterm birth, SGA, abnormal 5-minute Apgar score, and congenital defects, showed no significant associations after controlling for baseline characteristics and comorbidities. These findings indicate that the associations between PTSD and adverse pregnancy outcomes, particularly cesarean section and preterm birth, were more pronounced among women aged ≤35 years. Table 3.Adverse pregnancy outcomes in women with PTSD: a comparison between maternal age groups.Adverse pregnancy outcomes in different age groups (Mother with PTSD vs. Mother without PTSD)Mother with PTSD vs. Mother without PTSDCrude ORAdjust ORaWomen ≤ 35years old Cesarean section1.207** (1.095–1.33)1.220*** (1.105–1.348) Stillbirth1.069 (0.643–1.778)1.070 (0.643–1.781) Low birth weight1.146 (0.984–1.334)1.168 (0.999–1.366) Preterm1.173* (1.013–1.358)1.197* (1.029–1.392) Small for gestational age1.050 (0.857–1.285)1.058 (0.858–1.305) 5 min Apgar score (abnormal)1.260 (0.825–1.924)1.263 (0.826–1.93) Congenital defect0.833 (0.459–1.51)0.839 (0.462–1.523)Women > 35years old Cesarean section1.016 (0.841–1.229)1.017 (0.838–1.234) Stillbirth0.938 (0.461–1.908)0.919 (0.449–1.879) Low birth weight1.264 (0.965–1.655)1.292 (0.974–1.713) Preterm1.246 (0.959–1.617)1.26 (0.962–1.651) Small for gestational age1.043 (0.694–1.568)1.059 (0.686–1.634) 5 min Apgar score (abnormal)1.227 (0.653–2.304)1.252 (0.663–2.363) Congenital defect0.496 (0.185–1.327)0.504 (0.188–1.356)Notes: aadjustment for baseline characteristics and comorbidities. *p < .05 **p < .01 ***p < .001. Table 3.Adverse pregnancy outcomes in women with PTSD: a comparison between maternal age groups.Adverse pregnancy outcomes in different age groups (Mother with PTSD vs. Mother without PTSD)Mother with PTSD vs. Mother without PTSDCrude ORAdjust ORaWomen ≤ 35years old Cesarean section1.207** (1.095–1.33)1.220*** (1.105–1.348) Stillbirth1.069 (0.643–1.778)1.070 (0.643–1.781) Low birth weight1.146 (0.984–1.334)1.168 (0.999–1.366) Preterm1.173* (1.013–1.358)1.197* (1.029–1.392) Small for gestational age1.050 (0.857–1.285)1.058 (0.858–1.305) 5 min Apgar score (abnormal)1.260 (0.825–1.924)1.263 (0.826–1.93) Congenital defect0.833 (0.459–1.51)0.839 (0.462–1.523)Women > 35years old Cesarean section1.016 (0.841–1.229)1.017 (0.838–1.234) Stillbirth0.938 (0.461–1.908)0.919 (0.449–1.879) Low birth weight1.264 (0.965–1.655)1.292 (0.974–1.713) Preterm1.246 (0.959–1.617)1.26 (0.962–1.651) Small for gestational age1.043 (0.694–1.568)1.059 (0.686–1.634) 5 min Apgar score (abnormal)1.227 (0.653–2.304)1.252 (0.663–2.363) Congenital defect0.496 (0.185–1.327)0.504 (0.188–1.356)Notes: aadjustment for baseline characteristics and comorbidities. *p < .05 **p < .01 ***p < .001. Adverse pregnancy outcomes in women with PTSD: a comparison between maternal age groups. Notes: aadjustment for baseline characteristics and comorbidities. *p < .05 **p < .01 ***p < .001. Table 4 presents the subgroup analysis of adverse pregnancy outcomes stratified by maternal comorbidities. Among women with gestational diabetes mellitus, PTSD was significantly associated with increased odds of cesarean section (aOR: 1.452; 95% CI: 1.191-1.770) and low birth weight (aOR: 1.368; 95% CI: 1.020–1.834). In women with anemia, a significant association was observed only for preterm birth (aOR 1.444; 95% CI: 1.028–2.028). No significant associations with adverse outcomes were observed among women with gestational hypertension, anxiety, or depression (all p > .05). Furthermore, outcomes such as stillbirth, SGA, abnormal 5-minute Apgar scores, and congenital defects did not differ significantly across any subgroups. Table 4.Subgroup analysis of adverse pregnancy outcomes among women with PTSD.Adverse pregnancy outcomes in different groupsMother with PTSD vs. Mother without PTSDCrude ORAdjust ORaMother with gestational diabetes mellitus Cesarean section1.421** (1.173–1.722)1.452** (1.191–1.770) Stillbirth1.998 (0.68–5.869)2.016 (0.679–5.990) Low birth weight1.336* (1.005–1.776)1.368* (1.02–1.834) Preterm1.127 (0.863–1.471)1.140 (0.867–1.499) Small for gestational age1.153 (0.784–1.695)1.174 (0.782–1.764) 5 min Apgar score (abnormal)0.716 (0.316–1.621)0.711 (0.312–1.62) Congenital defect0.384 (0.136–1.081)0.385 (0.136–1.093)Mother with gestational hypertension Cesarean section1.159 (0.79–1.698)1.170 (0.783–1.750) Stillbirth1.991 (0.361–10.984)2.107 (0.367–12.111) Low birth weight1.076 (0.679–1.705)1.081 (0.674–1.735) Preterm1.308 (0.843–2.031)1.329 (0.843–2.095) Small for gestational age0.909 (0.474–1.744)0.851 (0.423–1.712) 5 min Apgar score (abnormal)1.014 (0.25–4.108)0.996 (0.231–4.297) Congenital defect––Mother with anxiety Cesarean section1.117 (0.958–1.303)1.124 (0.960–1.317) Stillbirth0.899 (0.473–1.707)0.898 (0.472–1.709) Low birth weight1.116 (0.887–1.404)1.124 (0.887–1.426) Preterm1.209 (0.973–1.502)1.228 (0.979–1.539) Small for gestational age0.884 (0.639–1.223)0.876 (0.626–1.226) 5 min Apgar score (abnormal)0.964 (0.565–1.644)0.963 (0.564–1.647) Congenital defect0.624 (0.203–1.911)0.621 (0.202–1.912)Mother with depression Cesarean section1.107 (0.935–1.311)1.115 (0.937–1.327) Stillbirth1.059 (0.543–2.065)1.058 (0.541–2.072) Low birth weight1.076 (0.839–1.381)1.082 (0.836–1.401) Preterm1.151 (0.913–1.450)1.162 (0.914–1.477) Small for gestational age0.870 (0.615–1.230)0.858 (0.596–1.235) 5 min Apgar score (abnormal)1.165 (0.678–2.003)1.169 (0.678–2.015) Congenital defect0.889 (0.342–2.312)0.888 (0.340–2.321)Mother with anemia Cesarean section1.175 (0.93–1.486)1.212 (0.949–1.546) Stillbirth2.254 (0.690–7.360)2.281 (0.694–7.496) Low birth weight1.357 (0.949–1.942)1.398 (0.971–2.013) Preterm1.426* (1.020–1.993)1.444* (1.028–2.028) Small for gestational age1.205 (0.712–2.038)1.267 (0.729–2.203) 5 min Apgar score (abnormal)0.701 (0.265–1.855)0.686 (0.256–1.834) Congenital defect0.838 (0.254–2.760)0.819 (0.245–2.741)Notes: aadjustment for baseline characteristics and comorbidities. *p < .05 **p < .01 Table 4.Subgroup analysis of adverse pregnancy outcomes among women with PTSD.Adverse pregnancy outcomes in different groupsMother with PTSD vs. Mother without PTSDCrude ORAdjust ORaMother with gestational diabetes mellitus Cesarean section1.421** (1.173–1.722)1.452** (1.191–1.770) Stillbirth1.998 (0.68–5.869)2.016 (0.679–5.990) Low birth weight1.336* (1.005–1.776)1.368* (1.02–1.834) Preterm1.127 (0.863–1.471)1.140 (0.867–1.499) Small for gestational age1.153 (0.784–1.695)1.174 (0.782–1.764) 5 min Apgar score (abnormal)0.716 (0.316–1.621)0.711 (0.312–1.62) Congenital defect0.384 (0.136–1.081)0.385 (0.136–1.093)Mother with gestational hypertension Cesarean section1.159 (0.79–1.698)1.170 (0.783–1.750) Stillbirth1.991 (0.361–10.984)2.107 (0.367–12.111) Low birth weight1.076 (0.679–1.705)1.081 (0.674–1.735) Preterm1.308 (0.843–2.031)1.329 (0.843–2.095) Small for gestational age0.909 (0.474–1.744)0.851 (0.423–1.712) 5 min Apgar score (abnormal)1.014 (0.25–4.108)0.996 (0.231–4.297) Congenital defect––Mother with anxiety Cesarean section1.117 (0.958–1.303)1.124 (0.960–1.317) Stillbirth0.899 (0.473–1.707)0.898 (0.472–1.709) Low birth weight1.116 (0.887–1.404)1.124 (0.887–1.426) Preterm1.209 (0.973–1.502)1.228 (0.979–1.539) Small for gestational age0.884 (0.639–1.223)0.876 (0.626–1.226) 5 min Apgar score (abnormal)0.964 (0.565–1.644)0.963 (0.564–1.647) Congenital defect0.624 (0.203–1.911)0.621 (0.202–1.912)Mother with depression Cesarean section1.107 (0.935–1.311)1.115 (0.937–1.327) Stillbirth1.059 (0.543–2.065)1.058 (0.541–2.072) Low birth weight1.076 (0.839–1.381)1.082 (0.836–1.401) Preterm1.151 (0.913–1.450)1.162 (0.914–1.477) Small for gestational age0.870 (0.615–1.230)0.858 (0.596–1.235) 5 min Apgar score (abnormal)1.165 (0.678–2.003)1.169 (0.678–2.015) Congenital defect0.889 (0.342–2.312)0.888 (0.340–2.321)Mother with anemia Cesarean section1.175 (0.93–1.486)1.212 (0.949–1.546) Stillbirth2.254 (0.690–7.360)2.281 (0.694–7.496) Low birth weight1.357 (0.949–1.942)1.398 (0.971–2.013) Preterm1.426* (1.020–1.993)1.444* (1.028–2.028) Small for gestational age1.205 (0.712–2.038)1.267 (0.729–2.203) 5 min Apgar score (abnormal)0.701 (0.265–1.855)0.686 (0.256–1.834) Congenital defect0.838 (0.254–2.760)0.819 (0.245–2.741)Notes: aadjustment for baseline characteristics and comorbidities. *p < .05 **p < .01 Subgroup analysis of adverse pregnancy outcomes among women with PTSD. Notes: aadjustment for baseline characteristics and comorbidities. *p < .05 **p < .01 Discussion This population-based study, using the Taiwan NHIRD, is the first in Asia to provide real-world evidence on the impact of PTSD within 1 year before delivery on birth outcomes. While previous research suggests that demographic factors like age, low income, and psychological comorbidities may influence PTSD risks (Brewin et al., 2000; Dailey et al., 2011; Ozer et al., 2003; Sareen, 2014), our research employed propensity score matching to control for these variables. Our study identified association between PTSD and higher risks of low birth weight and preterm birth in infants. Also, in women with PTSD aged ≤35 years, higher rates of cesarean section was noted compared with those without PTSD. This association was not evident in women aged > 35 years. In contrast, no significant associations were observed for congenital defects, stillbirth, SGA, or abnormal Apgar scores after adjustment. These findings may help reduce psychological stress among expectant mothers and their families by clarifying that PTSD does not appear to increase the risk of major neonatal complications. Despite this reassurance, the elevated risks identified for cesarean section, low birth weight, and preterm birth suggest that mental health needs may be insufficiently addressed in current obstetric care standards (Padin et al., 2022). Therefore, our results support integrating routine antenatal assessments of maternal psychological well-being into comprehensive prenatal care, which is essential for promoting holistic maternal and infant health. Our results align with prior research predominantly conducted in Western populations, indicating that maternal prenatal PTSD is linked to a higher risk of low birth weight and preterm birth (Alsallum et al., 2025; Sanjuan et al., 2021; Varela et al., 2023; Xiong et al., 2008; Yonkers et al., 2014; Zitoun et al., 2025). The consistency of these findings across both Western and our Taiwanese and Asian nationwide study suggests that the biological impact of PTSD on perinatal outcomes may transcend geographic and cultural boundaries. Our study identified a significant association between PTSD and low birth weight. Low birth weight, defined as a birth weight of less than 2,500 g, is a critical predictor of neonatal mortality (Crump et al., 2024). While the etiology of low birth weight is multifactorial and includes factors such as fetal chromosomal aberrations, maternal age, chronic maternal medical problems before or during pregnancy, multiple gestations, and maternal socioeconomic and educational status (Ahmed, 2022; Boghossian et al., 2012; Khan et al., 2018; Khan et al., 2020; Singh et al., 2009), its prevalence is typically concentrated in low- and middle-income countries, accounted for 95.6% of newborns (Ahmed, 2022). Notably, despite Taiwan’s classification as a high-income country with a relatively low baseline prevalence of low birth weight, our findings indicate that PTSD remains a significant independent risk factor. One potential mechanism underlying this association involves maternal nutritional status. Girma et al. found that inadequate iron or folic acid supplementation and maternal undernutrition were independently associated with low birth weight (Girma et al., 2019). Avalos et al. noted that women with prenatal depression had around two times the odds of poor diet quality compared to women without prenatal depression (Avalos et al., 2020). Additional evidence also suggests that less healthy dietary patterns are associated with more severe depressive symptoms (Ekinci & Sanlier, 2023; Paans et al., 2019). Given that depressive symptoms and negative mood alterations are commonly observed in PTSD, similar dietary vulnerability may also be present among affected mothers. Our findings are consistent with prior cross-sectional studies and review articles indicating that maternal prenatal PTSD is linked to a higher risk of low birth weight in infants (Sanjuan et al., 2021; Xiong et al., 2008). Consequently, these findings underscore the importance of integrating both mental health screening and nutritional assessment into routine prenatal care to mitigate risks to maternal and infant health. Our findings indicate that pregnant women with PTSD have a significantly higher risk of preterm birth compared with matched controls. Preterm birth, defined as delivery before 37 weeks of gestation, is a leading cause of neonatal mortality and morbidity (Jańczewska et al., 2023; Quinn et al., 2016). These results align with those of previous studies. Yonkers et al. found elevated rates of preterm birth among women with PTSD. There was a 4-fold increased risk of preterm birth in women with likely diagnoses of both PTSD and major depressive episodes (Yonkers et al., 2014). A potential biological mechanism underlying this association may involve maternal obesity. Women with PTSD have been reported to have higher rates of overweight and obesity, and elevated body mass index (BMI) is a recognised risk factor for preterm birth. In adults, obesity is defined as a BMI ≥ 30 kg/m². Evidence suggests that patients with PTSD tend to have higher rates of obesity and are at increased risk of weight gain (Kubzansky et al., 2014). Nagai et al. further reported that obesity predicts PTSD recovery trajectories (Nagai et al., 2021), and another study found that decreases in BMI are associated with significant reductions in PTSD and depressive symptoms (Johannessen & Berntsen, 2013). Therefore, an elevated BMI among women with PTSD may partially explain the higher risk of preterm birth observed in this study. However, BMI data were not available in the NHIRD, limiting our ability to directly assess this pathway. Future studies incorporating anthropometric measurements are needed to investigate this potential mechanism more rigorously. Previous research suggests that the association between prenatal PTSD and lower birth weight or gestational age is driven by the sustained activation of the maternal hypothalamic-pituitary-adrenal axis in response to chronic psychological stress (Bowers & Yehuda, 2016; Matsas et al., 2023). Immune system dysregulation with increase in inflammatory factors and a reduction in anti-inflammatory factors in patients with PTSD might cause inflammation and other complications during pregnancy, which might be potential pathways of maternal PTSD and low birthweight or preterm birth (Sun et al., 2021; Zitoun et al., 2025). Although most studies have focused on psychological adjustments such as anxiety, depression, and posttraumatic stress reactions among mothers after delivering preterm infants (Białas et al., 2025; Grand et al., 2024), the reverse relationship has received limited attention. Future research exploring how pregnancy-specific stress and coping mechanisms influence birth outcomes would enhance preventive strategies. We also observed that among women younger than 35 years, those with PTSD had higher rates of cesarean section compared with those without PTSD. This association was not evident in women older than 35 years. Advanced maternal age (AMA), defined as age older than 35 years, is inherently associated with increased risks of obstetric complications such as stillbirth, fetal growth restriction, gestational diabetes, and hypertension (Frick, 2021; Pinheiro et al., 2019). In addition, a positive association between AMA and cesarean section is well-established (Rydahl et al., 2019). The absence of a significant association in this stratum should be interpreted with caution, and several factors may account for this finding. The elevated baseline cesarean risk associated with AMA may obscure the specific contribution of PTSD in this population. In addition, women of advanced maternal age may have greater socioeconomic resources and social support, which may foster psychological resilience and reduce PTSD-related childbirth anxiety and requests for elective cesarean delivery (Barclay & Myrskylä, 2016; Rydahl et al., 2019). Furthermore, clinical decision-making may also differ by age: in younger women with fewer medical indications, PTSD-related anxiety may influence delivery mode, whereas in older women, heightened vigilance for age-related complications may attenuate the influence of psychiatric symptoms on delivery decisions (Rydahl et al., 2019). This study has several notable strengths. First, to our knowledge, this is the first study in Asia to use real-world data to examine the association between PTSD and adverse pregnancy outcomes. Second, we employed propensity score matching to balance the baseline differences between pregnant women with and without PTSD, thereby minimising confounding bias. Third, the use of the NHIRD enabled the inclusion of a substantially larger sample size than that used in previous studies, providing sufficient statistical power to detect associations with adverse pregnancy outcomes. However, several limitations should be noted. First, the NHIRD lacks detailed clinical information, including PTSD symptom severity, laboratory data, and lifestyle factors. In addition, information regarding PTSD status and symptom trajectories during pregnancy was unavailable. Moreover, because PTSD and pre-existing comorbidities were ascertained within the same one-year baseline period before the index delivery, their temporal sequence could not be determined, and whether these comorbidities preceded or followed PTSD onset remains unclear. Second, PTSD diagnoses were identified from medical records; therefore, the prevalence of PTSD may have been underestimated due to undiagnosed cases. Third, because the study population was predominantly of Han ethnicity, the findings may not be fully generalisable to other populations. Fourth, this study focused on immediate pregnancy and neonatal outcomes; long-term health outcomes for offspring were not assessed. Future studies are needed to address these limitations, and incorporating longitudinal assessments of PTSD symptoms during pregnancy may help clarify the respective contributions of pre-pregnancy PTSD and PTSD trajectories to adverse pregnancy outcomes. Conclusions Our study indicates that women with pre-delivery PTSD face slightly increased risks of cesarean delivery, low birth weight, and preterm birth. Importantly, no significant associations were found for congenital anomalies, stillbirth, SGA, or abnormal Apgar scores. These findings may offer reassurance to expectant mothers while underscoring the need for clinical awareness rather than alarm. Integrating routine mental health monitoring into prenatal care may help manage these risks and support overall maternal well-being. Supplementary Material Supplementary table 1_v2.docx